{
  "docId": "019de072-f015-70b3-a108-700a038da3d5",
  "docSlug": "ab0daada6947ab44927f267f74789e9c",
  "documentTitle": "Bionomics | Investor Presentation Deck | 16 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 16,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a list-based framework to justify the clinical development path.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f015-70b3-a108-700a038da3d5/8",
  "deckHref": "/decks/019de072-f015-70b3-a108-700a038da3d5",
  "deckJsonHref": "/decks/019de072-f015-70b3-a108-700a038da3d5.json",
  "deckAnchorHref": "/decks/019de072-f015-70b3-a108-700a038da3d5#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.5,
        "x": 0.43,
        "y": 0.15
      },
      "kind": "list",
      "text": "ANTI-PANIC: Single doses reduce panic symptoms & intensity in healthy volunteers experiencing a CCK-4 induced panic attack",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cffd0eb-b3ff-46e1-bd5b-90aed0dc5fbe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.5,
        "x": 0.43,
        "y": 0.75
      },
      "kind": "list",
      "text": "UNMET NEED: No acute treatments are approved for SAD; represents potential for rapid path to market",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ce56210-ce24-4176-801f-29494c650aa7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.5,
        "x": 0.43,
        "y": 0.45
      },
      "kind": "list",
      "text": "REDUCES PERCEPTION OF THREAT: Single doses reduce threat avoidance behavior in GAD patients performing a behavioral task",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fb484fe-b134-4438-98ed-1ef84c871cc8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.5,
        "x": 0.43,
        "y": 0.3
      },
      "kind": "list",
      "text": "ANTI-ANXIETY: Single doses reduce amygdala activation in GAD patients performing the Emotional Faces task during fMRI",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "936b08b1-c0da-4891-93c5-afbd7a564b8b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.5,
        "x": 0.43,
        "y": 0.6
      },
      "kind": "list",
      "text": "FAST-ACTING: Pharmacokinetics of reformulated BNC210 tablet are ideal for acute dosing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbc8dba2-b463-4ba5-bada-6935db686d0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.12,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Compelling Rationale for BNC210 as an Acute Treatment in Social Anxiety Disorder",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66ec53aa-786f-4a8a-891d-cc2cbc44887a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.08,
        "y": 0.03
      },
      "kind": "title",
      "text": "BNC210 is in an Ongoing Phase 2 PREVAIL Study for Acute Social Anxiety Disorder",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "65c9934d-d38f-48f9-b9a3-1c0371e0260c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "73f0aebb-0a44-49f4-af1f-de33d34999a4",
      "evidence": "Structured list of clinical benefits and market rationale",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 8,
      "beatId": "e98c942b-e5ba-4e34-9076-9b609ceab426",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The deck presents BNC210 as a potential solution with a compelling rationale and promising results",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "78fc056c-ae43-4691-bb01-042247be6fe2",
      "evidence": "The deck highlights the significant unmet need and market opportunity",
      "position": 0,
      "objective": "What is the cost of not addressing anxiety disorders and PTSD?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 11,
      "from": 8,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "061d4993-85b0-4818-8e44-b43269fb1025",
      "evidence": "The deck presents a compelling rationale for BNC210 in ongoing studies",
      "position": 1,
      "objective": "Why is now the right time for BNC210?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.7,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}